Supply Chain

Country's Ministry of Public Health chooses cannabinoid pharma company as its medical supplier

Supply chain management and logistics company boosts its US presence

Company says it will be able to produce an estimated 12 million doses per month

Pair of agreements expands packaging company's international network

While clock now ticking for life sciences companies to comply with the new data standards, opportunities in the offing to simplify manufacturing and the supply chain

Acquisition is 3PL provider's largest one yet

The importance of thinking strategically about the infrastructure and foresight needed to scale up CGTs—not as treatments of last resort, but first choice

Between both Covid-19 vaccines, an additional 350 million doses are being sent to Europe this year

Authorization should activate distribution of hundreds of millions of doses to countries involved with COVAX effort

UK cell and gene therapy location expected to be cGMP-ready by mid-2022

As efficiencies increase, company aims to cut time from 110 to about 60 days, according to a published report

Report: After data displayed minimal effectiveness, government pauses vaccine rollout

Last year’s numbers indicate historic lows

Two-dose COVAXIN currently under EUA in India

Following last week's announcement of supply decrease, company raises projection by 9 million

Komodo-BHI agreement grows patient database to 325M

Terms provide equitable access to Covid-19 vaccine

Cold-chain deal strives to contribute to vaccine distribution efforts

GlobalData predicts that RPM will be the prevailing industry trend in 2021

Alliance strives to develop novel AAV vectors

Aims to replicate the logistics of on-site testing sites to create "micro-to-mega" vaccination sites

Agreement with Amgen includes payments possibly totaling over $240M

Acquires Kymab in deal worth up to $1.45B

Report: Newly acquired German manufacturing facility could provide 750 million of them

Agreement allows for international distribution and storage